Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 38 studies | 33% ± 13% | |
| naive B cell | 18 studies | 29% ± 6% | |
| memory B cell | 18 studies | 32% ± 7% | |
| plasma cell | 17 studies | 43% ± 15% | |
| oligodendrocyte | 16 studies | 44% ± 18% | |
| astrocyte | 16 studies | 33% ± 16% | |
| plasmacytoid dendritic cell | 16 studies | 35% ± 11% | |
| oligodendrocyte precursor cell | 14 studies | 42% ± 19% | |
| microglial cell | 13 studies | 43% ± 16% | |
| GABAergic neuron | 8 studies | 35% ± 16% | |
| IgA plasma cell | 7 studies | 33% ± 15% | |
| IgG plasma cell | 6 studies | 25% ± 7% | |
| endothelial cell | 6 studies | 21% ± 2% | |
| plasmablast | 5 studies | 41% ± 16% | |
| glutamatergic neuron | 5 studies | 41% ± 16% | |
| precursor B cell | 5 studies | 54% ± 12% | |
| pro-B cell | 5 studies | 45% ± 15% | |
| retina horizontal cell | 5 studies | 43% ± 9% | |
| cardiac muscle cell | 5 studies | 29% ± 6% | |
| kidney loop of Henle epithelial cell | 4 studies | 19% ± 3% | |
| immature B cell | 4 studies | 43% ± 13% | |
| amacrine cell | 4 studies | 36% ± 20% | |
| Mueller cell | 4 studies | 38% ± 10% | |
| dendritic cell | 4 studies | 33% ± 12% | |
| macrophage | 4 studies | 28% ± 15% | |
| interneuron | 4 studies | 32% ± 6% | |
| ependymal cell | 3 studies | 34% ± 15% | |
| neuron | 3 studies | 35% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 14 studies | 33% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 27889.78 | 2641 / 2642 | 100% | 90.95 | 703 / 705 |
| prostate | 80% | 1930.87 | 197 / 245 | 99% | 19.43 | 499 / 502 |
| thymus | 73% | 1087.14 | 478 / 653 | 96% | 12.98 | 580 / 605 |
| kidney | 82% | 1478.38 | 73 / 89 | 85% | 11.86 | 765 / 901 |
| adrenal gland | 56% | 809.90 | 145 / 258 | 92% | 26.33 | 211 / 230 |
| ovary | 98% | 2425.12 | 177 / 180 | 43% | 4.21 | 184 / 430 |
| breast | 36% | 630.67 | 167 / 459 | 69% | 8.92 | 769 / 1118 |
| skin | 6% | 81.38 | 108 / 1809 | 96% | 74.18 | 453 / 472 |
| eye | 0% | 0 | 0 / 0 | 100% | 100.88 | 80 / 80 |
| spleen | 100% | 3951.95 | 241 / 241 | 0% | 0 | 0 / 0 |
| uterus | 82% | 1565.74 | 140 / 170 | 14% | 3.23 | 63 / 459 |
| heart | 92% | 3295.92 | 791 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 19% | 255.46 | 62 / 328 | 68% | 9.32 | 121 / 178 |
| bladder | 71% | 1442.48 | 15 / 21 | 13% | 1.22 | 64 / 504 |
| esophagus | 67% | 1549.99 | 970 / 1445 | 16% | 1.65 | 30 / 183 |
| intestine | 68% | 1427.54 | 655 / 966 | 14% | 1.36 | 72 / 527 |
| stomach | 50% | 733.72 | 179 / 359 | 19% | 1.83 | 54 / 286 |
| lung | 29% | 389.52 | 169 / 578 | 36% | 3.33 | 417 / 1155 |
| liver | 3% | 33.80 | 6 / 226 | 50% | 5.22 | 204 / 406 |
| peripheral blood | 40% | 1174.39 | 373 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 34% | 9.38 | 10 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 1.37 | 7 / 45 |
| blood vessel | 5% | 73.14 | 67 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 3% | 42.16 | 40 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 1% | 16.00 | 9 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001662 | Biological process | behavioral fear response |
| GO_0007168 | Biological process | receptor guanylyl cyclase signaling pathway |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
| GO_0007626 | Biological process | locomotory behavior |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031681 | Molecular function | G-protein beta-subunit binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GNG7 |
| Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 G protein subunit gamma 7 |
| Synonyms | GNGT7 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. Plays a role in the regulation of adenylyl cyclase signaling in certain regions of the brain. Plays a role in the formation or stabilzation of a G protein heterotrimer (G(olf) subunit alpha-beta-gamma-7) that is required for adenylyl cyclase activity in the striatum (By similarity). . |
| Accessions | ENST00000382159.8 K7ESC6 ENST00000587867.1 O60262 |